Share Price and Basic Stock Data
Last Updated: January 14, 2026, 8:28 pm
| PEG Ratio | -5.30 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
BASF India Ltd operates in the chemicals sector, focusing on organic chemicals, with a current market price of ₹3,604 and a market capitalization of ₹15,599 Cr. The company reported a total revenue of ₹13,645 Cr for the fiscal year ending March 2023. Revenue has shown a consistent upward trajectory, rising from ₹13,100 Cr in March 2022 and is projected to reach ₹15,162 Cr in March 2025. Quarterly sales figures reveal a steady increase, with ₹3,707 Cr reported in September 2023, up from ₹3,582 Cr in September 2022. This growth trajectory indicates strong demand for BASF’s products, aligning with industry trends that favour sustainable and innovative chemical solutions. The company’s operating profit margin (OPM) stood at 4% for the fiscal year 2025, reflecting tighter margins amid rising costs. This performance suggests that while sales are increasing, managing operational costs will be crucial to maintaining profitability as the market evolves.
Profitability and Efficiency Metrics
The profitability of BASF India Ltd is reflected in its net profit of ₹399 Cr for the trailing twelve months (TTM), with a net profit margin of 3.29% reported for March 2025. The operating profit for the same period was ₹747 Cr, indicating an operating profit margin (OPM) of 5.45%. The return on equity (ROE) of 13.65% and return on capital employed (ROCE) of 16.85% underscore the company’s ability to generate returns on shareholders’ equity and capital efficiently. Compared to the typical sector range, these figures represent a moderate performance level, suggesting room for improvement as the industry averages for ROE often hover around 15-20%. Additionally, the company recorded a cash conversion cycle (CCC) of 23 days, which is relatively efficient compared to industry standards, indicating effective management of working capital. However, the declining quarterly net profits in the last fiscal year, particularly the drop to ₹47 Cr in March 2025, raises concerns about sustainability in profitability.
Balance Sheet Strength and Financial Ratios
BASF India Ltd’s balance sheet reflects a solid foundation with total reserves amounting to ₹3,771 Cr and borrowings of ₹144 Cr, leading to a low leverage ratio. The interest coverage ratio (ICR) stands impressively at 53.17x, indicating that the company generates sufficient earnings to cover its interest obligations comfortably. The price-to-book value (P/BV) ratio of 5.25x suggests that the stock is trading at a premium compared to its book value, which stood at ₹844.79 per share as of March 2025. This premium may reflect investor confidence in the company’s future growth prospects. Additionally, the current ratio of 1.55x and quick ratio of 0.92x are indicative of adequate liquidity in meeting short-term liabilities. However, the rising total liabilities, which reached ₹8,330 Cr in March 2025, could pose risks if not managed effectively, especially as the company navigates an increasingly competitive market landscape.
Shareholding Pattern and Investor Confidence
The shareholding structure of BASF India Ltd indicates strong promoter confidence, with promoters holding 73.33% of the equity. This stability is complemented by a modest presence of foreign institutional investors (FIIs) at 4.14% and domestic institutional investors (DIIs) at 6.43%. The public shareholding stands at 16.09%, reflecting a diversified investor base. Notably, the number of shareholders has fluctuated, decreasing to 63,572 by September 2025 from 55,430 in December 2022, which may suggest a consolidation trend among investors. The consistent promoter holding indicates confidence in the company’s strategic direction, while the gradual increase in institutional ownership could be a positive sign of institutional interest in BASF. However, the declining number of public shareholders may imply reduced retail participation, which could affect market liquidity and the stock’s volatility in the future.
Outlook, Risks, and Final Insight
BASF India Ltd’s outlook remains cautiously optimistic, backed by strong revenue growth and a robust balance sheet. However, the company faces significant risks, including rising operational costs that could compress margins, as evidenced by the declining net profit trend. Furthermore, the chemicals industry is subject to regulatory changes and environmental challenges that may impact production costs and operational flexibility. The company’s ability to innovate and adapt to market demands will be critical in maintaining its competitive edge. If BASF can leverage its strengths in operational efficiency and strong promoter backing while addressing profitability concerns, it could potentially navigate the challenges ahead effectively. Conversely, failure to manage cost pressures or adapt to market dynamics could hinder its growth trajectory and investor confidence in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 77.1 Cr. | 216 | 456/192 | 179 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,095 Cr. | 8,950 | 14,250/8,150 | 51.4 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 30.2 Cr. | 101 | 329/93.4 | 15.0 | 26.9 | 0.99 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 224 Cr. | 280 | 435/163 | 12.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,554.50 Cr | 1,468.73 | 60.50 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,582 | 2,898 | 3,277 | 3,375 | 3,707 | 3,326 | 3,360 | 3,967 | 4,248 | 3,759 | 3,189 | 3,752 | 3,904 |
| Expenses | 3,394 | 2,843 | 3,143 | 3,177 | 3,473 | 3,114 | 3,114 | 3,654 | 4,047 | 3,588 | 3,126 | 3,530 | 3,750 |
| Operating Profit | 188 | 55 | 134 | 198 | 234 | 212 | 246 | 312 | 201 | 170 | 63 | 222 | 154 |
| OPM % | 5% | 2% | 4% | 6% | 6% | 6% | 7% | 8% | 5% | 5% | 2% | 6% | 4% |
| Other Income | 10 | 12 | 27 | 9 | 16 | 27 | 25 | 36 | 18 | 19 | 43 | 21 | 27 |
| Interest | 4 | 3 | 2 | 8 | 2 | 3 | 3 | 5 | 3 | 4 | 4 | 5 | 8 |
| Depreciation | 45 | 46 | 47 | 47 | 47 | 49 | 48 | 47 | 45 | 48 | 38 | 38 | 37 |
| Profit before tax | 149 | 18 | 112 | 152 | 200 | 187 | 219 | 297 | 171 | 138 | 64 | 201 | 136 |
| Tax % | 24% | 41% | 27% | 26% | 26% | 25% | 26% | 26% | 25% | 25% | 27% | 27% | 25% |
| Net Profit | 113 | 11 | 82 | 113 | 149 | 140 | 162 | 221 | 128 | 104 | 47 | 147 | 101 |
| EPS in Rs | 26.13 | 2.46 | 19.03 | 26.03 | 34.45 | 32.36 | 37.31 | 50.96 | 29.56 | 23.93 | 10.88 | 34.00 | 23.34 |
Last Updated: January 2, 2026, 7:31 am
Below is a detailed analysis of the quarterly data for BASF India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,904.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,752.00 Cr. (Jun 2025) to 3,904.00 Cr., marking an increase of 152.00 Cr..
- For Expenses, as of Sep 2025, the value is 3,750.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,530.00 Cr. (Jun 2025) to 3,750.00 Cr., marking an increase of 220.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 154.00 Cr.. The value appears to be declining and may need further review. It has decreased from 222.00 Cr. (Jun 2025) to 154.00 Cr., marking a decrease of 68.00 Cr..
- For OPM %, as of Sep 2025, the value is 4.00%. The value appears to be declining and may need further review. It has decreased from 6.00% (Jun 2025) to 4.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Jun 2025) to 27.00 Cr., marking an increase of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Jun 2025) to 8.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 37.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 38.00 Cr. (Jun 2025) to 37.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 136.00 Cr.. The value appears to be declining and may need further review. It has decreased from 201.00 Cr. (Jun 2025) to 136.00 Cr., marking a decrease of 65.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Jun 2025) to 25.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 101.00 Cr.. The value appears to be declining and may need further review. It has decreased from 147.00 Cr. (Jun 2025) to 101.00 Cr., marking a decrease of 46.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 23.34. The value appears to be declining and may need further review. It has decreased from 34.00 (Jun 2025) to 23.34, marking a decrease of 10.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,430 | 4,706 | 4,749 | 5,073 | 5,583 | 6,026 | 7,595 | 9,558 | 13,100 | 13,645 | 13,767 | 15,162 | 14,604 |
| Expenses | 4,146 | 4,572 | 4,642 | 4,802 | 5,238 | 5,861 | 7,316 | 8,926 | 12,188 | 12,958 | 12,878 | 14,415 | 13,994 |
| Operating Profit | 284 | 133 | 107 | 271 | 346 | 165 | 279 | 633 | 911 | 687 | 890 | 747 | 609 |
| OPM % | 6% | 3% | 2% | 5% | 6% | 3% | 4% | 7% | 7% | 5% | 6% | 5% | 4% |
| Other Income | -3 | 39 | 173 | 27 | 182 | 139 | -4 | 419 | 37 | 53 | 76 | 116 | 110 |
| Interest | 16 | 96 | 148 | 142 | 113 | 85 | 83 | 38 | 17 | 14 | 16 | 16 | 20 |
| Depreciation | 71 | 142 | 163 | 169 | 153 | 147 | 181 | 174 | 171 | 182 | 191 | 178 | 160 |
| Profit before tax | 194 | -66 | -30 | -12 | 261 | 72 | 10 | 840 | 760 | 543 | 759 | 670 | 538 |
| Tax % | 34% | 2% | 0% | 13% | 6% | -14% | -131% | 34% | 22% | 26% | 26% | 25% | |
| Net Profit | 128 | -67 | -30 | -14 | 246 | 82 | 23 | 553 | 595 | 403 | 563 | 499 | 399 |
| EPS in Rs | 29.54 | -15.46 | -7.02 | -3.26 | 56.95 | 18.88 | 5.28 | 127.67 | 137.42 | 93.08 | 130.15 | 115.33 | 92.15 |
| Dividend Payout % | 14% | -26% | -14% | -31% | 5% | 26% | 57% | 8% | 4% | 9% | 12% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -152.34% | 55.22% | 53.33% | 1857.14% | -66.67% | -71.95% | 2304.35% | 7.59% | -32.27% | 39.70% | -11.37% |
| Change in YoY Net Profit Growth (%) | 0.00% | 207.57% | -1.89% | 1803.81% | -1923.81% | -5.28% | 2376.30% | -2296.75% | -39.86% | 71.97% | -51.07% |
BASF India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 58% |
| 3 Years: | -7% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 26% |
| 3 Years: | 13% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:40 am
Balance Sheet
Last Updated: December 10, 2025, 2:27 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 |
| Reserves | 1,207 | 1,119 | 1,073 | 1,059 | 1,301 | 1,370 | 1,201 | 1,743 | 2,293 | 2,658 | 3,180 | 3,614 | 3,771 |
| Borrowings | 1,067 | 1,600 | 1,349 | 1,275 | 868 | 912 | 822 | 286 | 122 | 106 | 156 | 157 | 144 |
| Other Liabilities | 1,717 | 1,406 | 1,311 | 1,498 | 1,635 | 1,524 | 2,764 | 3,072 | 3,652 | 3,758 | 3,853 | 4,517 | 3,542 |
| Total Liabilities | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 | 7,500 |
| Fixed Assets | 526 | 1,351 | 1,289 | 1,222 | 1,117 | 957 | 965 | 817 | 763 | 793 | 759 | 694 | 682 |
| CWIP | 792 | 74 | 55 | 33 | 27 | 42 | 23 | 53 | 100 | 19 | 61 | 84 | 120 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 213 | 213 |
| Other Assets | 2,716 | 2,743 | 2,433 | 2,619 | 2,702 | 2,850 | 3,842 | 4,274 | 5,247 | 5,753 | 6,413 | 7,339 | 6,485 |
| Total Assets | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 | 7,500 |
Below is a detailed analysis of the balance sheet data for BASF India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 43.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 43.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,771.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,614.00 Cr. (Mar 2025) to 3,771.00 Cr., marking an increase of 157.00 Cr..
- For Borrowings, as of Sep 2025, the value is 144.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 157.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,542.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,517.00 Cr. (Mar 2025) to 3,542.00 Cr., marking a decrease of 975.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,500.00 Cr.. The value appears to be improving (decreasing). It has decreased from 8,330.00 Cr. (Mar 2025) to 7,500.00 Cr., marking a decrease of 830.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 682.00 Cr.. The value appears to be declining and may need further review. It has decreased from 694.00 Cr. (Mar 2025) to 682.00 Cr., marking a decrease of 12.00 Cr..
- For CWIP, as of Sep 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 36.00 Cr..
- For Investments, as of Sep 2025, the value is 213.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 213.00 Cr..
- For Other Assets, as of Sep 2025, the value is 6,485.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,339.00 Cr. (Mar 2025) to 6,485.00 Cr., marking a decrease of 854.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8,330.00 Cr. (Mar 2025) to 7,500.00 Cr., marking a decrease of 830.00 Cr..
Notably, the Reserves (3,771.00 Cr.) exceed the Borrowings (144.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 283.00 | 132.00 | 106.00 | 270.00 | -522.00 | -747.00 | -543.00 | 347.00 | 789.00 | 581.00 | 734.00 | 590.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 72 | 80 | 77 | 71 | 63 | 68 | 79 | 73 | 63 | 67 | 60 |
| Inventory Days | 136 | 106 | 85 | 93 | 94 | 99 | 93 | 73 | 66 | 71 | 68 | 80 |
| Days Payable | 138 | 98 | 117 | 120 | 117 | 103 | 133 | 126 | 112 | 108 | 114 | 118 |
| Cash Conversion Cycle | 69 | 80 | 49 | 50 | 48 | 59 | 28 | 25 | 26 | 26 | 21 | 23 |
| Working Capital Days | 49 | 43 | 43 | 36 | 28 | 32 | 10 | 26 | 34 | 37 | 44 | 40 |
| ROCE % | 12% | 0% | -2% | 5% | 9% | 1% | 6% | 23% | 34% | 20% | 25% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Small Cap Fund | 763,051 | 2.78 | 317.19 | 763,051 | 2025-04-22 17:25:40 | 0% |
| Tata Large & Mid Cap Fund | 263,657 | 1.25 | 109.6 | N/A | N/A | N/A |
| Quant Small Cap Fund | 243,197 | 0.34 | 101.09 | 170,585 | 2025-12-15 01:00:05 | 42.57% |
| ICICI Prudential Smallcap Fund | 23,493 | 0.12 | 9.77 | 112,260 | 2025-12-07 01:05:46 | -79.07% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Diluted EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Cash EPS (Rs.) | 156.38 | 174.30 | 135.13 | 176.81 | 167.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Dividend / Share (Rs.) | 20.00 | 15.00 | 8.00 | 6.00 | 10.00 |
| Revenue From Operations / Share (Rs.) | 3502.51 | 3180.29 | 3151.95 | 3026.04 | 2207.98 |
| PBDIT / Share (Rs.) | 190.97 | 223.07 | 167.26 | 216.08 | 150.00 |
| PBIT / Share (Rs.) | 149.91 | 178.91 | 125.20 | 176.68 | 109.83 |
| PBT / Share (Rs.) | 154.75 | 175.32 | 125.53 | 175.54 | 194.03 |
| Net Profit / Share (Rs.) | 115.32 | 130.13 | 93.07 | 137.41 | 127.65 |
| PBDIT Margin (%) | 5.45 | 7.01 | 5.30 | 7.14 | 6.79 |
| PBIT Margin (%) | 4.27 | 5.62 | 3.97 | 5.83 | 4.97 |
| PBT Margin (%) | 4.41 | 5.51 | 3.98 | 5.80 | 8.78 |
| Net Profit Margin (%) | 3.29 | 4.09 | 2.95 | 4.54 | 5.78 |
| Return on Networth / Equity (%) | 13.65 | 17.47 | 14.91 | 25.46 | 30.93 |
| Return on Capital Employeed (%) | 16.85 | 22.73 | 18.99 | 30.89 | 24.40 |
| Return On Assets (%) | 5.99 | 7.78 | 6.13 | 9.73 | 10.74 |
| Asset Turnover Ratio (%) | 1.95 | 2.00 | 2.15 | 2.33 | 1.96 |
| Current Ratio (X) | 1.55 | 1.59 | 1.47 | 1.37 | 1.27 |
| Quick Ratio (X) | 0.92 | 1.04 | 0.87 | 0.83 | 0.78 |
| Inventory Turnover Ratio (X) | 6.18 | 2.09 | 2.27 | 2.23 | 1.81 |
| Dividend Payout Ratio (NP) (%) | 13.00 | 6.14 | 6.44 | 7.27 | 2.35 |
| Dividend Payout Ratio (CP) (%) | 9.59 | 4.58 | 4.43 | 5.65 | 1.78 |
| Earning Retention Ratio (%) | 87.00 | 93.86 | 93.56 | 92.73 | 97.65 |
| Cash Earning Retention Ratio (%) | 90.41 | 95.42 | 95.57 | 94.35 | 98.22 |
| Interest Coverage Ratio (X) | 53.17 | 62.18 | 52.05 | 53.54 | 17.28 |
| Interest Coverage Ratio (Post Tax) (X) | 30.75 | 37.27 | 28.86 | 34.33 | 5.01 |
| Enterprise Value (Cr.) | 18377.30 | 13821.16 | 9498.38 | 13225.93 | 8803.28 |
| EV / Net Operating Revenue (X) | 1.21 | 1.00 | 0.69 | 1.01 | 0.92 |
| EV / EBITDA (X) | 22.23 | 14.31 | 13.12 | 14.14 | 13.56 |
| MarketCap / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| Retention Ratios (%) | 86.99 | 93.85 | 93.55 | 92.72 | 97.64 |
| Price / BV (X) | 5.25 | 4.48 | 3.65 | 5.72 | 5.03 |
| Price / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| EarningsYield | 0.02 | 0.03 | 0.04 | 0.04 | 0.06 |
After reviewing the key financial ratios for BASF India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Diluted EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 156.38. This value is within the healthy range. It has decreased from 174.30 (Mar 24) to 156.38, marking a decrease of 17.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Dividend / Share (Rs.), as of Mar 25, the value is 20.00. This value exceeds the healthy maximum of 3. It has increased from 15.00 (Mar 24) to 20.00, marking an increase of 5.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3,502.51. It has increased from 3,180.29 (Mar 24) to 3,502.51, marking an increase of 322.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 190.97. This value is within the healthy range. It has decreased from 223.07 (Mar 24) to 190.97, marking a decrease of 32.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 149.91. This value is within the healthy range. It has decreased from 178.91 (Mar 24) to 149.91, marking a decrease of 29.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 154.75. This value is within the healthy range. It has decreased from 175.32 (Mar 24) to 154.75, marking a decrease of 20.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 115.32. This value is within the healthy range. It has decreased from 130.13 (Mar 24) to 115.32, marking a decrease of 14.81.
- For PBDIT Margin (%), as of Mar 25, the value is 5.45. This value is below the healthy minimum of 10. It has decreased from 7.01 (Mar 24) to 5.45, marking a decrease of 1.56.
- For PBIT Margin (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has decreased from 5.62 (Mar 24) to 4.27, marking a decrease of 1.35.
- For PBT Margin (%), as of Mar 25, the value is 4.41. This value is below the healthy minimum of 10. It has decreased from 5.51 (Mar 24) to 4.41, marking a decrease of 1.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 5. It has decreased from 4.09 (Mar 24) to 3.29, marking a decrease of 0.80.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.65. This value is below the healthy minimum of 15. It has decreased from 17.47 (Mar 24) to 13.65, marking a decrease of 3.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.85. This value is within the healthy range. It has decreased from 22.73 (Mar 24) to 16.85, marking a decrease of 5.88.
- For Return On Assets (%), as of Mar 25, the value is 5.99. This value is within the healthy range. It has decreased from 7.78 (Mar 24) to 5.99, marking a decrease of 1.79.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.95. It has decreased from 2.00 (Mar 24) to 1.95, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 1.55, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.92, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 6.18, marking an increase of 4.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 20. It has increased from 6.14 (Mar 24) to 13.00, marking an increase of 6.86.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 20. It has increased from 4.58 (Mar 24) to 9.59, marking an increase of 5.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 87.00. This value exceeds the healthy maximum of 70. It has decreased from 93.86 (Mar 24) to 87.00, marking a decrease of 6.86.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 90.41. This value exceeds the healthy maximum of 70. It has decreased from 95.42 (Mar 24) to 90.41, marking a decrease of 5.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.17. This value is within the healthy range. It has decreased from 62.18 (Mar 24) to 53.17, marking a decrease of 9.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 30.75. This value is within the healthy range. It has decreased from 37.27 (Mar 24) to 30.75, marking a decrease of 6.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 18,377.30. It has increased from 13,821.16 (Mar 24) to 18,377.30, marking an increase of 4,556.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 1.21, marking an increase of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 22.23. This value exceeds the healthy maximum of 15. It has increased from 14.31 (Mar 24) to 22.23, marking an increase of 7.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For Retention Ratios (%), as of Mar 25, the value is 86.99. This value exceeds the healthy maximum of 70. It has decreased from 93.85 (Mar 24) to 86.99, marking a decrease of 6.86.
- For Price / BV (X), as of Mar 25, the value is 5.25. This value exceeds the healthy maximum of 3. It has increased from 4.48 (Mar 24) to 5.25, marking an increase of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BASF India Ltd:
- Net Profit Margin: 3.29%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.85% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.65% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 30.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.92
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 40.7 (Industry average Stock P/E: 60.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.29%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Unit Nos. 10A, 10B, 10C (Part), 10th Floor, Godrej One, Pirojshanagar, Mumbai Maharashtra 400079 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradip P Shah | Chairman |
| Mr. Alexander Gerding | Managing Director |
| Mr. Anil Choudhary | Whole Time Director |
| Dr. Ramkumar Dhruva | Director |
| Mrs. Shyamala Gopinath | Director |
| Mr. Marcelo Rocha Lu | Director |
| Mr. Bahram Vakil | Director |
| Ms. Sonia Singh | Director |
| Mr. Narendranath J Baliga | Whole Time Director |
| Mr. Manohar Kamath | Director - Legal |
FAQ
What is the intrinsic value of BASF India Ltd?
BASF India Ltd's intrinsic value (as of 14 January 2026) is ₹3951.51 which is 9.22% higher the current market price of ₹3,618.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹15,667 Cr. market cap, FY2025-2026 high/low of ₹5,424/3,580, reserves of ₹3,771 Cr, and liabilities of ₹7,500 Cr.
What is the Market Cap of BASF India Ltd?
The Market Cap of BASF India Ltd is 15,667 Cr..
What is the current Stock Price of BASF India Ltd as on 14 January 2026?
The current stock price of BASF India Ltd as on 14 January 2026 is ₹3,618.
What is the High / Low of BASF India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BASF India Ltd stocks is ₹5,424/3,580.
What is the Stock P/E of BASF India Ltd?
The Stock P/E of BASF India Ltd is 40.7.
What is the Book Value of BASF India Ltd?
The Book Value of BASF India Ltd is 881.
What is the Dividend Yield of BASF India Ltd?
The Dividend Yield of BASF India Ltd is 0.55 %.
What is the ROCE of BASF India Ltd?
The ROCE of BASF India Ltd is 18.0 %.
What is the ROE of BASF India Ltd?
The ROE of BASF India Ltd is 13.7 %.
What is the Face Value of BASF India Ltd?
The Face Value of BASF India Ltd is 10.0.